REPORT ID 4375

Global Atrial Fibrillation Drugs Market Research Report 2017

Publish Date
18-Dec-17
Pages
117
Format
Electronic (PDF)

In this report, the global Atrial Fibrillation Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Atrial Fibrillation Drugs in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Atrial Fibrillation Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Boehringer Ingelheim
    Janssen Pharmaceuticals
    Sanofi
    ARCA Biopharma
    Armetheon
    Baxter
    Bristol-Myers Squibb
    ChanRx
    Daiichi Sankyo
    Gilead Sciences
    HUYA Biosciences
    Menarini
    Pfizer
    Pierre Fabre
    Servier
    Xention
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Anti-Arrhythmic Drugs
    Anti-Coagulant Drugs
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Paroxysmal Atrial Fibrillation
    Persistent Atrial Fibrillation
    Longstanding Persistent Afib

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Atrial Fibrillation Drugs Market Research Report 2017
1 Atrial Fibrillation Drugs Market Overview
    1.1 Product Overview and Scope of Atrial Fibrillation Drugs
    1.2 Atrial Fibrillation Drugs Segment by Type (Product Category)
        1.2.1 Global Atrial Fibrillation Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Atrial Fibrillation Drugs Production Market Share by Type (Product Category) in 2016
        1.2.3 Anti-Arrhythmic Drugs
        1.2.4 Anti-Coagulant Drugs
    1.3 Global Atrial Fibrillation Drugs Segment by Application
        1.3.1 Atrial Fibrillation Drugs Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Paroxysmal Atrial Fibrillation
        1.3.3 Persistent Atrial Fibrillation
        1.3.4 Longstanding Persistent Afib
    1.4 Global Atrial Fibrillation Drugs Market by Region (2012-2022)
        1.4.1 Global Atrial Fibrillation Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Atrial Fibrillation Drugs (2012-2022)
        1.5.1 Global Atrial Fibrillation Drugs Revenue Status and Outlook (2012-2022)
        1.5.2 Global Atrial Fibrillation Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Atrial Fibrillation Drugs Market Competition by Manufacturers
    2.1 Global Atrial Fibrillation Drugs Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Atrial Fibrillation Drugs Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Atrial Fibrillation Drugs Production and Share by Manufacturers (2012-2017)
    2.2 Global Atrial Fibrillation Drugs Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Atrial Fibrillation Drugs Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Atrial Fibrillation Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Atrial Fibrillation Drugs Market Competitive Situation and Trends
        2.5.1 Atrial Fibrillation Drugs Market Concentration Rate
        2.5.2 Atrial Fibrillation Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Atrial Fibrillation Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Atrial Fibrillation Drugs Capacity and Market Share by Region (2012-2017)
    3.2 Global Atrial Fibrillation Drugs Production and Market Share by Region (2012-2017)
    3.3 Global Atrial Fibrillation Drugs Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Atrial Fibrillation Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Atrial Fibrillation Drugs Consumption by Region (2012-2017)
    4.2 North America Atrial Fibrillation Drugs Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Atrial Fibrillation Drugs Production, Consumption, Export, Import (2012-2017)
    4.4 China Atrial Fibrillation Drugs Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Atrial Fibrillation Drugs Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Atrial Fibrillation Drugs Production, Consumption, Export, Import (2012-2017)
    4.7 India Atrial Fibrillation Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Atrial Fibrillation Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Atrial Fibrillation Drugs Production and Market Share by Type (2012-2017)
    5.2 Global Atrial Fibrillation Drugs Revenue and Market Share by Type (2012-2017)
    5.3 Global Atrial Fibrillation Drugs Price by Type (2012-2017)
    5.4 Global Atrial Fibrillation Drugs Production Growth by Type (2012-2017)

6 Global Atrial Fibrillation Drugs Market Analysis by Application
    6.1 Global Atrial Fibrillation Drugs Consumption and Market Share by Application (2012-2017)
    6.2 Global Atrial Fibrillation Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Atrial Fibrillation Drugs Manufacturers Profiles/Analysis
    7.1 Boehringer Ingelheim
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Atrial Fibrillation Drugs Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Boehringer Ingelheim Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Janssen Pharmaceuticals
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Atrial Fibrillation Drugs Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Janssen Pharmaceuticals Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Sanofi
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Atrial Fibrillation Drugs Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Sanofi Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 ARCA Biopharma
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Atrial Fibrillation Drugs Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 ARCA Biopharma Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Armetheon
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Atrial Fibrillation Drugs Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Armetheon Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Baxter
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Atrial Fibrillation Drugs Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Baxter Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Bristol-Myers Squibb
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Atrial Fibrillation Drugs Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Bristol-Myers Squibb Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 ChanRx
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Atrial Fibrillation Drugs Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 ChanRx Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Daiichi Sankyo
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Atrial Fibrillation Drugs Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Daiichi Sankyo Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Gilead Sciences
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Atrial Fibrillation Drugs Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Gilead Sciences Atrial Fibrillation Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 HUYA Biosciences
    7.12 Menarini
    7.13 Pfizer
    7.14 Pierre Fabre
    7.15 Servier
    7.16 Xention

8 Atrial Fibrillation Drugs Manufacturing Cost Analysis
    8.1 Atrial Fibrillation Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Atrial Fibrillation Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Atrial Fibrillation Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Atrial Fibrillation Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Atrial Fibrillation Drugs Market Forecast (2017-2022)
    12.1 Global Atrial Fibrillation Drugs Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Atrial Fibrillation Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Atrial Fibrillation Drugs Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Atrial Fibrillation Drugs Price and Trend Forecast (2017-2022)
    12.2 Global Atrial Fibrillation Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Atrial Fibrillation Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Atrial Fibrillation Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Atrial Fibrillation Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Atrial Fibrillation Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Atrial Fibrillation Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Atrial Fibrillation Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Atrial Fibrillation Drugs Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Atrial Fibrillation Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer